|
Computerized histomorphometric features of glandular architecture predict risk of biochemical recurrence following radical prostatectomy: A multisite study. |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Merck Sharp & Dohme |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Patents, Royalties, Other Intellectual Property - methods for diagnosing and treating prostate cancer |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Pathology Laboratory of South-Western Finland |
Consulting or Advisory Role - Roche |
Travel, Accommodations, Expenses - MSD |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Philips Healthcare |
Travel, Accommodations, Expenses - Philips Healthcare |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |